ARDS - Aridis Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 557.16M
Enterprise Value 341.25M
Trailing P/E N/A
Forward P/E 1-2.52
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)16.53
Price/Book (mrq)3.05
Enterprise Value/Revenue 311.93
Enterprise Value/EBITDA 6-1.71

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-708.24%

Management Effectiveness

Return on Assets (ttm)-66.76%
Return on Equity (ttm)-132.74%

Income Statement

Revenue (ttm)3.46M
Revenue Per Share (ttm)0.67
Quarterly Revenue Growth (yoy)217.40%
Gross Profit (ttm)-20.24M
EBITDA -24.17M
Net Income Avi to Common (ttm)-23.37M
Diluted EPS (ttm)-4.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.31M
Total Cash Per Share (mrq)2.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.52
Book Value Per Share (mrq)2.31

Cash Flow Statement

Operating Cash Flow (ttm)-27.65M
Levered Free Cash Flow (ttm)-19.83M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 35.62%
52 Week High 313.85
52 Week Low 36.92
50-Day Moving Average 38.99
200-Day Moving Average 39.34

Share Statistics

Avg Vol (3 month) 32.87k
Avg Vol (10 day) 35.13k
Shares Outstanding 58.11M
Float 4.79M
% Held by Insiders 145.04%
% Held by Institutions 10.26%
Shares Short (May 31, 2019) 412.58k
Short Ratio (May 31, 2019) 47.48
Short % of Float (May 31, 2019) 40.22%
Short % of Shares Outstanding (May 31, 2019) 40.16%
Shares Short (prior month Apr 30, 2019) 413.53k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A